1FW2 vs 3NK: Side-by-Side Comparison
Compare WUXI BIOLOGICS-00000083 (1FW2) and ALPHAMAB ONCOLO.DL-000002 (3NK) side by side: market cap EUR 15.30B vs EUR 736.18M. Financials, growth and model signals on Bullrun.
| Metric | 1FW2 | 3NK |
|---|---|---|
| Company | WUXI BIOLOGICS-00000083 | ALPHAMAB ONCOLO.DL-000002 |
| Country / Exchange | China · F | China · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 15.30B | EUR 736.18M |
| P/E ratio | 24.8 | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 18.68B | EUR 566.24M |
| Revenue growth YoY | +9.6% | -11.5% |
| Net income | EUR 3.36B | EUR -113.94M |
| Gross margin | 41.0% | 88.8% |
| Diluted EPS | 0.78 | -0.12 |